Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinsonโs disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.
์ข
๋ชฉ ์ฝ๋ AMRX
ํ์ฌ ์ด๋ฆAmneal Pharmaceuticals Inc
์์ฅ์ผNov 18, 2009
CEOPatel (Chintu)
์ง์ ์8100
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃNov 18
์ฃผ์400 Crossing Boulevard, 3rd Floor
๋์BRIDGEWATER
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐUnited States of America
์ฐํธ ๋ฒํธ08807
์ ํ19089473120
์น์ฌ์ดํธhttps://amneal.com/
์ข
๋ชฉ ์ฝ๋ AMRX
์์ฅ์ผNov 18, 2009
CEOPatel (Chintu)